Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	0.03 mg SM04690	112
Overall Study	STARTED	0.07 mg SM04690	117
Overall Study	STARTED	0.23 mg SM04690	110
Overall Study	STARTED	Placebo	116
Overall Study	COMPLETED	0.03 mg SM04690	103
Overall Study	COMPLETED	0.07 mg SM04690	107
Overall Study	COMPLETED	0.23 mg SM04690	95
Overall Study	COMPLETED	Placebo	97
Overall Study	NOT COMPLETED	0.03 mg SM04690	9
Overall Study	NOT COMPLETED	0.07 mg SM04690	10
Overall Study	NOT COMPLETED	0.23 mg SM04690	15
Overall Study	NOT COMPLETED	Placebo	19

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02536833/flow